⌘K

Home/Filings/4/0001618835-19-000202

4//SEC Filing

Culwell Kelly 4

Accession 0001618835-19-000202

CIK 0001618835other

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 5:14 PM ET

Size

4.9 KB

Accession

0001618835-19-000202

Insider Transaction Report

Form 4

Period: 2019-11-25

Evofem Biosciences, Inc.EVFM

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2019-11-25$6.22/sh−5,187$32,263→ 44,538 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 25, 2019. No shares were sold in connection with this transaction.

Documents

1 file

4
wf-form4_157480646585981.xmlPrimary
FORM 4

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1

filerCIK 0001726183

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 5:14 PM ET
Size: 4.9 KB

View on SEC.gov